The 6th Imric Retreat

α-Synuclein’s as a regulator of Ras in Parkinson’s Disease

Jenna CongdonLoeffler Lama Naamneh Dima Khatib Omar Benjamin Rivera-Maya
Department of biochemistry and endocrinology - faculty of medicine, Hebrew University

Parkinson`s disease (PD) involves progressive loss of dopaminergic neurons, and α-Synuclein (α-Syn) is the major protein component of the lewy bodies, the pathological hallmark of the disease. α-Syn interacts with membrane phospholipids and has been shown to facilitate protein palmitoylation, a reversible post-translational modification that attach a palmitate to specific Cystein residues on the protein. Ras proteins require proper plasma membrane localization, regulated in part by palmitoylation, to transition between inactive GDP-bound and active GTP-bound states. Recent findings from our laboratory demonstrate that α-Syn activates Phosphoinositide 3-kinase (PI3K), a Ras effector protein. We now aim at defining the mechanism of activation.
We hypothesize that α-Syn activates Ras palmitoylation to regulate PI3K/AKT pathway activity.
We demonstrate that α-Syn expression enhances H-Ras and N-Ras localization to the plasma membrane, increasing Ras palmitoylation and activity. Using site specific mutagenesis to replace the palmitoylated Cystein residues of H-Ras (C181S/C184S) and N-Ras (C181S), we demonstrate that Ras palmitoylation is required for α-Syn to activate the PI3K/AKT pathway. To further define the mechanism of α-Syn action in palmitoylating Ras proteins, we will assess the kinetics of Ras palmitoylation in the presence of α-Syn expression using click-chemistry pulse–chase assays and employ CRISPRi to identify enzymes involved in α-Syn-mediated regulation of Ras palmitoylation and trafficking to the plasma membrane, including zDHHC9, ABHD17A, and Rab27B. Defining how α-Syn modulates Ras signaling may uncover a previously unrecognized mechanism of α-Syn toxicity related to PD.